A new Central Chronic Medication Dispensing and Distribution (CCMDD) Pick-up Point facility has been launched in Verulam, KwaZulu-Natal (KZN) to improve access to life-saving medicine.
The CCMDD programme is a National Department of Health (NDoH) initiative aimed at improving access to chronic medication for stable chronic patients in the public sector. The new facility is made possible through a partnership between the NDoH and the Cipla Foundation.
CEO of Cipla Medpro, parent body of the Cipla Foundation, Paul Miller, says that the programme holds a number of benefits for public sector patients.
“Many patients on chronic medication travel long distances and have a long wait at busy public-sector facilities just to collect their chronic medication. The CCMDD Pick-up Point facilities create the opportunity for these patients to collect their chronic medication quickly and easily and at a site closer to their home or place of work,” said Miller.
The CCMDD programme not only enables patients to collect their medication at more convenient times and locations, but also reduces the patient-load at local clinics.
“The CCMDD Pick-up Point facilities provide secure medication drop-off and collection points, so patients do not need to visit local public-sector clinics as often, thus reducing foot traffic at the clinics and allowing more time for the care of sick patients there,” said Miller.
The NDoH CCMDD programme is well established in South Africa with close to 400,000 patients already enrolled.
“This project creates the opportunity to demonstrate how a partnership between government, NGOs and the private sector can generate benefit for all parties in the healthcare sector and especially for the patient at the end of the line,” said Miller.
Stable public-sector patients on chronic medication may be enrolled on the CCMDD programme when they visit the hospital or clinic where they currently collect their medication.
“The Cipla Foundation is excited to be a part of this project and we look forward to helping make life-saving medication more accessible to all South Africans,” concluded Miller.